Cargando…

Characterising diabetes in Kazakhstan: a cluster analysis

BACKGROUND: Diabetes is a global pandemic, affecting 537 million adults worldwide in 2021. Diabetes is much more complex than the classification into type 1 diabetes and type 2 diabetes suggests. We aimed to identify homogeneous groups of patients with diabetes based on routinely collected measureme...

Descripción completa

Detalles Bibliográficos
Autores principales: Taurbekova, B, Sarsenov, R, Fazli, S, Salimzhanov, A, Mun, V, Atageldiyeva, K, Zhumambayeva, S, Sarria-Santamera, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597042/
http://dx.doi.org/10.1093/eurpub/ckad160.1132
_version_ 1785125248706805760
author Taurbekova, B
Sarsenov, R
Fazli, S
Salimzhanov, A
Mun, V
Atageldiyeva, K
Zhumambayeva, S
Sarria-Santamera, A
author_facet Taurbekova, B
Sarsenov, R
Fazli, S
Salimzhanov, A
Mun, V
Atageldiyeva, K
Zhumambayeva, S
Sarria-Santamera, A
author_sort Taurbekova, B
collection PubMed
description BACKGROUND: Diabetes is a global pandemic, affecting 537 million adults worldwide in 2021. Diabetes is much more complex than the classification into type 1 diabetes and type 2 diabetes suggests. We aimed to identify homogeneous groups of patients with diabetes based on routinely collected measurements using unsupervised, data-driven cluster analysis. METHODS: We analyzed the data from Electronic Medical Records of 558 patients with newly diagnosed diabetes from 4 outpatient clinics in Astana. We performed a k-means cluster analysis of 9 routinely measured variables using the KMeans function (iterations=3 million) from the Scikit-Learn Python library. RESULTS: Cluster 1, consisting of 176 (31,5%) patients, was defined by late-onset diabetes, relatively low blood pressure (BP) and body mass index (BMI), moderate metabolic derangements, and comparably low glomerular filtration rate (GFR). The 83 (14,9%) patients in cluster 2 were characterized by a late manifestation of diabetes, high BP and BMI, relatively poor glycemic control, moderate dyslipidemia, and comparably low GFR. Cluster 3, including 98 (17,6%) patients, was represented by a low age at onset, comparably low BP and BMI, moderately poor glycemic and lipid controls, and high GFR. The 110 (19,7%) patients in cluster 4 had late-onset diabetes, high BP and BMI, subcompensated diabetes, poor lipid control, and relatively low GFR. Cluster 5, which involved 91 (16,3%) patients, was characterized by comparably low BP and BMI, poor glycemic control, modest dyslipidemia, and high GFR. CONCLUSIONS: We intend to continue the project for further conducting a prospective study with dynamic monitoring of study participants, tracking specific patterns in the development of diabetic complications in each cluster. The results of this work will contribute to the development of a model for identifying patients with an initially predictable course of diabetes and a high risk of its complications at the time of diagnosis. KEY MESSAGES: • We identified five clusters of patients with diabetes with clinically significant characteristics in each cluster. • Identification of subgroups of patients with an initially predictable course can be useful for recognizing those at highest risk of complications and applying personalized treatment strategies.
format Online
Article
Text
id pubmed-10597042
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105970422023-10-25 Characterising diabetes in Kazakhstan: a cluster analysis Taurbekova, B Sarsenov, R Fazli, S Salimzhanov, A Mun, V Atageldiyeva, K Zhumambayeva, S Sarria-Santamera, A Eur J Public Health Poster Displays BACKGROUND: Diabetes is a global pandemic, affecting 537 million adults worldwide in 2021. Diabetes is much more complex than the classification into type 1 diabetes and type 2 diabetes suggests. We aimed to identify homogeneous groups of patients with diabetes based on routinely collected measurements using unsupervised, data-driven cluster analysis. METHODS: We analyzed the data from Electronic Medical Records of 558 patients with newly diagnosed diabetes from 4 outpatient clinics in Astana. We performed a k-means cluster analysis of 9 routinely measured variables using the KMeans function (iterations=3 million) from the Scikit-Learn Python library. RESULTS: Cluster 1, consisting of 176 (31,5%) patients, was defined by late-onset diabetes, relatively low blood pressure (BP) and body mass index (BMI), moderate metabolic derangements, and comparably low glomerular filtration rate (GFR). The 83 (14,9%) patients in cluster 2 were characterized by a late manifestation of diabetes, high BP and BMI, relatively poor glycemic control, moderate dyslipidemia, and comparably low GFR. Cluster 3, including 98 (17,6%) patients, was represented by a low age at onset, comparably low BP and BMI, moderately poor glycemic and lipid controls, and high GFR. The 110 (19,7%) patients in cluster 4 had late-onset diabetes, high BP and BMI, subcompensated diabetes, poor lipid control, and relatively low GFR. Cluster 5, which involved 91 (16,3%) patients, was characterized by comparably low BP and BMI, poor glycemic control, modest dyslipidemia, and high GFR. CONCLUSIONS: We intend to continue the project for further conducting a prospective study with dynamic monitoring of study participants, tracking specific patterns in the development of diabetic complications in each cluster. The results of this work will contribute to the development of a model for identifying patients with an initially predictable course of diabetes and a high risk of its complications at the time of diagnosis. KEY MESSAGES: • We identified five clusters of patients with diabetes with clinically significant characteristics in each cluster. • Identification of subgroups of patients with an initially predictable course can be useful for recognizing those at highest risk of complications and applying personalized treatment strategies. Oxford University Press 2023-10-24 /pmc/articles/PMC10597042/ http://dx.doi.org/10.1093/eurpub/ckad160.1132 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Displays
Taurbekova, B
Sarsenov, R
Fazli, S
Salimzhanov, A
Mun, V
Atageldiyeva, K
Zhumambayeva, S
Sarria-Santamera, A
Characterising diabetes in Kazakhstan: a cluster analysis
title Characterising diabetes in Kazakhstan: a cluster analysis
title_full Characterising diabetes in Kazakhstan: a cluster analysis
title_fullStr Characterising diabetes in Kazakhstan: a cluster analysis
title_full_unstemmed Characterising diabetes in Kazakhstan: a cluster analysis
title_short Characterising diabetes in Kazakhstan: a cluster analysis
title_sort characterising diabetes in kazakhstan: a cluster analysis
topic Poster Displays
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597042/
http://dx.doi.org/10.1093/eurpub/ckad160.1132
work_keys_str_mv AT taurbekovab characterisingdiabetesinkazakhstanaclusteranalysis
AT sarsenovr characterisingdiabetesinkazakhstanaclusteranalysis
AT fazlis characterisingdiabetesinkazakhstanaclusteranalysis
AT salimzhanova characterisingdiabetesinkazakhstanaclusteranalysis
AT munv characterisingdiabetesinkazakhstanaclusteranalysis
AT atageldiyevak characterisingdiabetesinkazakhstanaclusteranalysis
AT zhumambayevas characterisingdiabetesinkazakhstanaclusteranalysis
AT sarriasantameraa characterisingdiabetesinkazakhstanaclusteranalysis